Dieci, Maria Vittoria http://orcid.org/0000-0002-3967-9861
Carbognin, Luisa
Miglietta, Federica
Canino, Fabio
Giorgi, Carlo Alberto
Cumerlato, Enrico
Amato, Ottavia
Massa, Davide
Griguolo, Gaia http://orcid.org/0000-0002-8782-4509
Genovesi, Elisa
Garufi, Giovanna
Giannarelli, Diana
Tornincasa, Antonio
Trudu, Lucia
Michieletto, Silvia
Saibene, Tania
Lo Mele, Marcello
Fassan, Matteo
Zarrilli, Giovanni
Piacentini, Federico
Bria, Emilio
Guarneri, Valentina
Funding for this research was provided by:
Istituto Oncologico Veneto (L02P03, L04P25, L04P11)
Università degli Studi di Padova (BIRD 2021, BIRD 2020, BIRD 2020, BIRD 2021)
Associazione Italiana per la Ricerca sul Cancro (22759)
Article History
Received: 7 June 2022
Revised: 21 October 2022
Accepted: 27 October 2022
First Online: 17 November 2022
Change Date: 2 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-022-02087-9
Ethics approval and consent to participate
: The study was approved by the ethics committee of participating centres, and all relevant ethical regulations have complied. Informed consent was obtained from all participants.
: Not applicable.
: MVD reports personal fees from Eli Lilly, MSD, Exact Sciences, Novartis, Pfizer, Seagen, outside the submitted work; FM reports personal fees from Roche, outside the submitted work; GG reports personal fees from Novartis, Eli Lilly, outside the submitted work; EB reports personal fees, non-financial support and other from MSD, AstraZeneca, Pfizer, Eli Lilly, BMS, Novartis and Roche; and grants from AstraZeneca and Roche, outside the submitted work; VG reports personal fees from Roche, Novartis, Eli Lilly, MSD, GSK, Gilead; outside the submitted work. The remaining authors declare no competing interests.